NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Bilibili Gets a Boost: JPMorgan Upgrades to Overweight, Sees Upside Thanks to AI Investments

JPMorgan bullish on BILI: AI investments fuel engagement, 25%+ ad revenue growth. "Solid profit compounder" with strong upside potential.

Bilibili Gets a Boost: JPMorgan Upgrades to Overweight, Sees Upside Thanks to AI Investments
Credit: Michael Nagle/Bloomberg
Already have an account? Sign in.
03/17/2026 · 5:38 PM
BILI
/ Read more

Feed↓

Novartis, Ionis Heart Drug Misses Phase 3 Goal Despite Cutting Lp(a)
Featured/ 09/04/2026 · 5:21 PM

Novartis, Ionis Heart Drug Misses Phase 3 Goal Despite Cutting Lp(a)

Novartis and Ionis said pelacarsen lowered Lp(a) but failed to cut heart attacks, strokes or deaths in a Phase 3 trial of 8,323 patients.

/ Subscriber only
Canaccord Initiates Belite Bio at Buy With $303 Target on Stargardt Therapy
09/04/2026 · 11:46 AM

Canaccord Initiates Belite Bio at Buy With $303 Target on Stargardt Therapy

Canaccord cites tinlarebant as the first drug shown to slow Stargardt lesion growth. The PDUFA date is February 12, 2027.

/ Subscriber only
AMC CEO Blasts Robinhood Over Tokenized Shares, Threatens SEC Action
09/04/2026 · 11:16 AM

AMC CEO Blasts Robinhood Over Tokenized Shares, Threatens SEC Action

AMC CEO Adam Aron calls Robinhood’s AMC stock tokens vile and a fake market, demands a halt, and considers an SEC complaint.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe